Cargando…
Evaluation of the Boson rapid Ag test vs RT–PCR for use as a self–testing platform
The gold standard test available for detecting COVID–19 patients is Real Time RT–PCR. However, this method is expensive, needing special equipment and skilled laboratory staff. Recently, less expensive antigen tests have become available, that could easily and rapidly identify new COVID–19 cases. Ou...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335347/ https://www.ncbi.nlm.nih.gov/pubmed/35998553 http://dx.doi.org/10.1016/j.diagmicrobio.2022.115786 |
_version_ | 1784759318715826176 |
---|---|
author | Leventopoulos, Michail Michou, Vassiliki Papadimitropoulos, Miltiadis Vourva, Evangelia Manias, Nikolaos George Kavvadas, Harilaos Panagiotis Nikolopoulos, Dimitris Tsilivakos, Vassilis Georgoulias, Georgios |
author_facet | Leventopoulos, Michail Michou, Vassiliki Papadimitropoulos, Miltiadis Vourva, Evangelia Manias, Nikolaos George Kavvadas, Harilaos Panagiotis Nikolopoulos, Dimitris Tsilivakos, Vassilis Georgoulias, Georgios |
author_sort | Leventopoulos, Michail |
collection | PubMed |
description | The gold standard test available for detecting COVID–19 patients is Real Time RT–PCR. However, this method is expensive, needing special equipment and skilled laboratory staff. Recently, less expensive antigen tests have become available, that could easily and rapidly identify new COVID–19 cases. Our objective was to evaluate the Boson Rapid Antigen Test Card versus the RT–rtPCR, using samples taken both by laymen (self–testing) and professionals. The sensitivity, specificity and accuracy rates were, 98.18%, 100.00%, and 99.28%, respectively. The positive and negative predictive values were 100.00% and 98.82%, respectively. The detection rate for asymptomatic patients was 90.48%, and detection rate for Ct values ≥30 was 91.67%. Our results indicate a high coincidence rate between the Boson and the referencing RT–rtPCR method, meeting the performance standards recommended by the WHO. Therefore, this test could facilitate a fast self–testing screening method, for the detection of infected individuals. |
format | Online Article Text |
id | pubmed-9335347 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Authors. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93353472022-07-29 Evaluation of the Boson rapid Ag test vs RT–PCR for use as a self–testing platform Leventopoulos, Michail Michou, Vassiliki Papadimitropoulos, Miltiadis Vourva, Evangelia Manias, Nikolaos George Kavvadas, Harilaos Panagiotis Nikolopoulos, Dimitris Tsilivakos, Vassilis Georgoulias, Georgios Diagn Microbiol Infect Dis Article The gold standard test available for detecting COVID–19 patients is Real Time RT–PCR. However, this method is expensive, needing special equipment and skilled laboratory staff. Recently, less expensive antigen tests have become available, that could easily and rapidly identify new COVID–19 cases. Our objective was to evaluate the Boson Rapid Antigen Test Card versus the RT–rtPCR, using samples taken both by laymen (self–testing) and professionals. The sensitivity, specificity and accuracy rates were, 98.18%, 100.00%, and 99.28%, respectively. The positive and negative predictive values were 100.00% and 98.82%, respectively. The detection rate for asymptomatic patients was 90.48%, and detection rate for Ct values ≥30 was 91.67%. Our results indicate a high coincidence rate between the Boson and the referencing RT–rtPCR method, meeting the performance standards recommended by the WHO. Therefore, this test could facilitate a fast self–testing screening method, for the detection of infected individuals. The Authors. Published by Elsevier Inc. 2022-11 2022-07-29 /pmc/articles/PMC9335347/ /pubmed/35998553 http://dx.doi.org/10.1016/j.diagmicrobio.2022.115786 Text en © 2022 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Leventopoulos, Michail Michou, Vassiliki Papadimitropoulos, Miltiadis Vourva, Evangelia Manias, Nikolaos George Kavvadas, Harilaos Panagiotis Nikolopoulos, Dimitris Tsilivakos, Vassilis Georgoulias, Georgios Evaluation of the Boson rapid Ag test vs RT–PCR for use as a self–testing platform |
title | Evaluation of the Boson rapid Ag test vs RT–PCR for use as a self–testing platform |
title_full | Evaluation of the Boson rapid Ag test vs RT–PCR for use as a self–testing platform |
title_fullStr | Evaluation of the Boson rapid Ag test vs RT–PCR for use as a self–testing platform |
title_full_unstemmed | Evaluation of the Boson rapid Ag test vs RT–PCR for use as a self–testing platform |
title_short | Evaluation of the Boson rapid Ag test vs RT–PCR for use as a self–testing platform |
title_sort | evaluation of the boson rapid ag test vs rt–pcr for use as a self–testing platform |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335347/ https://www.ncbi.nlm.nih.gov/pubmed/35998553 http://dx.doi.org/10.1016/j.diagmicrobio.2022.115786 |
work_keys_str_mv | AT leventopoulosmichail evaluationofthebosonrapidagtestvsrtpcrforuseasaselftestingplatform AT michouvassiliki evaluationofthebosonrapidagtestvsrtpcrforuseasaselftestingplatform AT papadimitropoulosmiltiadis evaluationofthebosonrapidagtestvsrtpcrforuseasaselftestingplatform AT vourvaevangelia evaluationofthebosonrapidagtestvsrtpcrforuseasaselftestingplatform AT maniasnikolaosgeorge evaluationofthebosonrapidagtestvsrtpcrforuseasaselftestingplatform AT kavvadasharilaospanagiotis evaluationofthebosonrapidagtestvsrtpcrforuseasaselftestingplatform AT nikolopoulosdimitris evaluationofthebosonrapidagtestvsrtpcrforuseasaselftestingplatform AT tsilivakosvassilis evaluationofthebosonrapidagtestvsrtpcrforuseasaselftestingplatform AT georgouliasgeorgios evaluationofthebosonrapidagtestvsrtpcrforuseasaselftestingplatform |